← Leaderboards
Larry Cripe
Indiana Univ-Purdue Univ At Indianapolis
$82,150
Attributed
$82,150
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$82,150 · 2
By mechanism
P30$82,150 · 1
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mitchell Goldman$10,867,864
- C. Conrad Johnston$0
- Kenneth H. Fife$1,137,888
- Munro Peacock$2,764,841
- Catherine Leitch$0
Others in their field
Top investigators on “Acute Myelogenous Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Brad H. Pollock · University Of Florida$28,646,726
- Gregory H Reaman · National Childhood Cancer Foundation$17,689,961
- Richard Aplenc · University Of Pennsylvania$16,894,374
- Daniel G Tenen · Beth Israel Deaconess Medical Center$16,073,131
Research focus
Acute Myelogenous LeukemiaAntineoplasticsClinical ResearchCombination ChemotherapyCytosine ArabinosideDaunorubicinHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer Chemotherapy
Grant awards (8)
Clinical Research Office$82,150
P30 · FY2004 · CA
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2002 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2001 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2000 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2000 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2000 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2000 · RR
LY335979, DAUNORUBICIN, CYTARABINE IN MYELOGENOUS LEUKEM$0
M01 · FY2000 · RR